MARKET

TTOO

TTOO

T2 Biosystems
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.290
-0.040
-1.72%
After Hours: 2.320 +0.03 +1.31% 16:35 02/26 EST
OPEN
2.260
PREV CLOSE
2.330
HIGH
2.440
LOW
2.170
VOLUME
5.96M
TURNOVER
--
52 WEEK HIGH
3.790
52 WEEK LOW
0.2350
MARKET CAP
338.82M
P/E (TTM)
-3.3881
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Canaccord Genuity Keeps Their Buy Rating on T2 Biosystems (TTOO)
In a report issued on February 18, Max Masucci from Canaccord Genuity maintained a Buy rating on T2 Biosystems (TTOO), with a price target of $3.50. The
SmarterAnalyst · 1d ago
Thinking about buying stock in Gamida Cell, Co-Diagnostics, T2 Biosystems, FSD Pharma, or Allena Pharmaceuticals?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GMDA, CODX, TTOO, HUGE, and ALNA.
PR Newswire - PRF · 2d ago
T2 Biosystems to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
LEXINGTON, Mass., Feb. 23, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the fourth quarter and full year 2020 after market...
GlobeNewswire · 3d ago
Packaged Wastewater Treatment Market Size, Share, Report 2020-2025, Industry Growth, Price Analysis, Trends, Outlook and Forecast
According to a new report by EMR titled, 'Global Packaged Wastewater Treatment Market Report and Forecast 2020-2025', the global packaged wastewater treatment market attained a value of nearly USD 17.56 billion in 2019. to attain a value of USD 31.98 bill...
SUPER MARKET RESEARCH · 02/18 06:49
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 9)
Benzinga · 02/09 13:10
GLUU, CCLP, AAME and INFI among after-hours movers
Gainers: [[GLUU]] +33.8%. [[CCLP]] +24.9%. [[TRITW]] +15.3%. [[VRNS]] +8.6%. [[ZNGA]] +6.8%.Losers: [[INFI]] -26.7%. [[ALNY]] -17.4%. [[ITCI]] -10.7%. [[AAME]] -7.9%. [[TTOO]] -6.3%.
Seekingalpha · 02/08 22:50
T2 Biosystems to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostics Tools Conference
GlobeNewswire · 02/08 21:07
Thinking about buying stock in InspireMD, iBio, Nokia, Novan, or T2 Biosystems?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NSPR, IBIO, NOK, NOVN, and TTOO.
PR Newswire - PRF · 02/08 15:45
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TTOO. Analyze the recent business situations of T2 Biosystems through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TTOO stock price target is 3.180 with a high estimate of 3.500 and a low estimate of 2.400.
EPS
Institutional Holdings
Institutions: 130
Institutional Holdings: 28.24M
% Owned: 19.08%
Shares Outstanding: 147.96M
TypeInstitutionsShares
Increased
19
3.01M
New
29
893.68K
Decreased
12
736.50K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.60%
Healthcare Equipment & Supplies
-0.59%
Key Executives
Non-Executive Chairman
John McDonough
President/Chief Executive Officer/Director
John Sperzel
Chief Financial Officer
John Sprague
Chief Operating Officer
Alec Barclay
Chief Scientific Officer
Thomas Lowery
Vice President/General Counsel
Michael Gibbs
Other
Aparna Ahuja
Other
Anthony Pare
Lead Director/Independent Director
John Cumming
Director
Seymour Liebman
Independent Director
Thierry Bernard
Independent Director
David Elsbree
Independent Director
Ninfa Saunders
Independent Director
Stan Lapidus
Independent Director
Robin Toft
  • Dividends
  • Splits
  • Insider Activity
No Data
About TTOO
T2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter (CFU/mL). The Company's initial development efforts target sepsis, hemostasis and Lyme disease. T2MR is a miniaturized, magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. Its platform detects a range of targets, including molecular targets, such as deoxyribonucleic acid (DNA), immunodiagnostics, such as proteins, and a range of hemostasis measurements. The Company offers T2Dx Instrument (T2Dx) and the T2Candida Panel.

Webull offers kinds of T2 Biosystems Inc stock information, including NASDAQ:TTOO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TTOO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TTOO stock methods without spending real money on the virtual paper trading platform.